LUMO Fund II
Autoscriber is unlocking the future of medical consultations through data – towards personalized, transparent, and accessible healthcare for all.
Autoscriber develops AI-powered speech recognition and natural language processing technologies to extract structured data from conversations between physicians and patients. In the context of the healthcare sector, the company aims to solve the most interesting AI challenge of our time: understanding human conversations.
The software effectively places a “digital scribe” in the consultation room that can support the doctor in real-time by drafting medical notes, providing relevant insights into the patient’s medical history, and analyzing patient and population trends. This approach also helps patients to take control of their health journey by enabling them to play back and share the information received by the doctor with their loved ones and to keep track of their symptoms and medications over time.